erlotinib hydrochloride has been researched along with divinyl sulfone in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (divinyl sulfone) | Trials (divinyl sulfone) | Recent Studies (post-2010) (divinyl sulfone) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 253 | 0 | 134 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiebchun, T; Auepattanapong, A; Choowongkomon, K; Khaikate, O; Kuhakarn, C; Mahalapbutr, P; Rungrotmongkol, T; Seetaha, S; Tabtimmai, L | 1 |
1 other study(ies) available for erlotinib hydrochloride and divinyl sulfone
| Article | Year |
|---|---|
Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies.
Topics: Cell Death; Cell Line, Tumor; Computer Simulation; ErbB Receptors; Erlotinib Hydrochloride; Humans; Hydrogen Bonding; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Kinase Inhibitors; Sulfones; Thermodynamics | 2021 |